[Extension of cervix cancer screening by visual methods to the community health centres in the district of Bamako].
Cervix cancer remains a public health problem in developing countries. These results are an assessment for multicentric study based on visual inspection of the cervix after application of acetiq acid (VIA) and lugol's iodine (VILI). The aim of this study is to determine the feasibility and the impact of this screening in the community health centres "CSCOM" in the district of Bamako. It was a prospective and multicentric study through 8 CSCOM, 3 Reference Centres "CSRéf", Hôpital Gabriel Touré (HGT) and National Institute of Public Health (INRSP) in Bamako. During 28 months, 5016 women aged through 25-49 years were screened. After their consent and questionnaire filling, the patient is comfortably settled for visual test. The repartition of screened patients by health level is: CSCOM (19.24% : 965/5016), CSRéf (48.64% : 2440/5016), HGT (32.12% : 1611/5016). In general, the positivity of tests was: 5.2% (VIA) and 6.8% (VILI). The positive women at the CSCOM level were oriented to the CSRéf or the HGT for the colposcopy, possible biopsy or care. At all 177 biopsies were done, and histological diagnosis were: 67 dysplasias, 3 early invasive carcinomas, 69 invasive carcinomas and 38 inflammatory metaplasic lesions or nonconclusives aspects. Patients with dysplasias or cancers were treated by cryotherapy, loop electrosurgical excision procedure (LEEP), cold-knife conization or surgery. This study showed that screening of cervical cancer by visual inspection is workable at CSCOM level. We wish a large diffusion of the method to the whole of the country.
Kamaté
B
B
laboratoire d'Anatomie Pathologique de l'Institut National de Recherche en Santé Publique (INRSP), BP 1771, Bamako. kamatebak@yahoo.fr
Traoré
C B
CB
Diallo
D
D
Sacko
R
R
Toure
M
M
Keita
B
B
Teguete
B
B
Traore
Y
Y
Diarra
M H D
MH
Ouattara
A T
AT
Traoré
A C
AC
Mariko
H
H
Dembele
Y
Y
Togola
B
B
Tall
K
K
Sanogo
A
A
Diané
M
M
Kaloga
I
I
Traoré
M
M
Dolo
A I
AI
Bayo
S
S
D019342:Acetic Acid; D000230:Adenocarcinoma / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D000328:Adult; D001706:Biopsy; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D004396:Coloring Agents; D003151:Community Health Centers / Q000458:organization & administration* / Q000706:statistics & numerical data; D005260:Female; D006297:Health Services Accessibility; D006785:Hospitals, University / Q000458:organization & administration / Q000706:statistics & numerical data; D006801:Humans; D007454:Iodides; D008302:Mali / Q000453:epidemiology; D008403:Mass Screening / Q000379:methods / Q000458:organization & administration* / Q000706:statistics & numerical data; D008679:Metaplasia; D008875:Middle Aged; D010808:Physical Examination; D011446:Prospective Studies; D013194:Staining and Labeling; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D002575:Uterine Cervicitis / Q000175:diagnosis / Q000453:epidemiology
D004396:Coloring Agents; D007454:Iodides; D019342:Acetic Acid; C010389:Lugol's solution